News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
261,020 Results
Type
Article (14022)
Company Profile (293)
Press Release (246705)
Section
Business (79535)
Career Advice (148)
Deals (13236)
Drug Delivery (32)
Drug Development (50787)
Employer Resources (31)
FDA (5695)
Job Trends (5171)
News (144808)
Policy (10080)
Tag
Academia (927)
Alliances (21511)
Alzheimer's disease (736)
Approvals (5661)
Artificial intelligence (61)
Bankruptcy (97)
Best Places to Work (4541)
Biotechnology (241)
Breast cancer (61)
Cancer (648)
Cardiovascular disease (52)
Career advice (129)
CAR-T (48)
Cell therapy (162)
Clinical research (40036)
Collaboration (211)
Compensation (93)
COVID-19 (1020)
C-suite (61)
Cystic fibrosis (61)
Data (697)
Diabetes (69)
Diagnostics (1197)
Earnings (28877)
Events (47005)
Executive appointments (164)
FDA (5954)
Funding (220)
Gene editing (53)
Gene therapy (134)
GLP-1 (300)
Government (1073)
Healthcare (6571)
Infectious disease (1053)
Inflammatory bowel disease (92)
IPO (7212)
Job creations (861)
Job search strategy (125)
Layoffs (184)
Legal (1377)
Lung cancer (107)
Manufacturing (69)
Medical device (2560)
Medtech (2561)
Mergers & acquisitions (6113)
Metabolic disorders (213)
Neuroscience (927)
NextGen Class of 2024 (2005)
Non-profit (845)
Northern California (856)
Obesity (120)
Opinion (91)
Parkinson's disease (56)
Patents (47)
People (24971)
Pharmaceutical (48)
Phase I (14085)
Phase II (18637)
Phase III (11808)
Pipeline (224)
Postmarket research (847)
Preclinical (5975)
Radiopharmaceuticals (203)
Rare diseases (151)
Real estate (1412)
Regulatory (8232)
Research institute (946)
Southern California (793)
Startups (1965)
United States (7077)
Vaccines (160)
Weight loss (76)
Date
Today (80)
Last 7 days (571)
Last 30 days (2025)
Last 365 days (20650)
2024 (18356)
2023 (22576)
2022 (27011)
2021 (28005)
2020 (23523)
2019 (16321)
2018 (11796)
2017 (13817)
2016 (11918)
2015 (14427)
2014 (10424)
2013 (7514)
2012 (7565)
2011 (7641)
2010 (7444)
Location
Africa (147)
Asia (16883)
Australia (2839)
California (1943)
Canada (667)
China (153)
Colorado (71)
Connecticut (80)
Europe (36454)
Florida (202)
Georgia (56)
Illinois (121)
Indiana (54)
Kansas (55)
Maryland (288)
Massachusetts (1595)
Michigan (47)
Minnesota (87)
New Jersey (512)
New York (573)
North Carolina (385)
Northern California (856)
Ohio (75)
Pennsylvania (412)
South America (207)
Southern California (793)
Texas (199)
Washington State (207)
261,020 Results for "macrophage therapeutics".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Carisma Therapeutics Presents Preclinical Proof of Concept Data Demonstrating the Anti-Fibrotic Potential of Engineered Macrophages at ASGCT 2024
Carisma Therapeutics Inc. announced new data demonstrating preclinical proof of concept using engineered anti-fibrotic macrophages for the treatment of liver fibrosis.
May 8, 2024
·
6 min read
Business
Macomics and the Institute of Oncology Research (IOR, Switzerland) Announce Macrophage Scientific Collaboration in Prostate Cancer Drug Development
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Andrea Alimonti at IOR, one of Switzerland’s leading research institutes.
June 19, 2024
·
5 min read
Press Releases
Pheast Presents New Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor, at SITC 2024
November 7, 2024
·
2 min read
Drug Development
Pheast Unveils First Preclinical Data for PHST001, an Anti-CD24 Macrophage Checkpoint Inhibitor
Pheast Therapeutics today announced the first presentation of preclinical data for PHST001, an anti-CD24 antibody drug candidate that is designed to block a key macrophage “don’t eat me” signal on cancer cells.
May 13, 2024
·
2 min read
Press Releases
Hemogenyx Pharmaceuticals PLC Announces Macrophage-Directed Therapies Summit Presentation
July 29, 2024
·
2 min read
Business
Macomics and IFOM (the AIRC Institute of Molecular Oncology) Announce Macrophage Scientific Collaboration
Macomics Ltd, a leader in macrophage drug discovery, announces that it has entered a scientific collaboration with Prof. Massimiliano Pagani from the IFOM, one of Italy’s leading research institutes in Cancer Research.
May 13, 2024
·
4 min read
Policy
Sobi Receives US FDA Fast Track Designation for Emapalumab-lzsg being investigated in Macrophage Activation Syndrome
Sobi North America, the North American affiliate of Swedish Orphan Biovitrum AB, announced that the US Food and Drug Administration has granted Fast Track designation to emapalumab-lzsg being investigated as a potential therapeutic option in patients with Macrophage Activation Syndrome.
May 24, 2024
·
5 min read
BioForest
Kineta to Present at the 5th Annual Macrophage-Directed Therapies Summit
Kineta, Inc. announced today that it will present at the 5th Annual Macrophage-Directed Therapies Summit, to be held on November 13-15, 2023 in Boston, MA.
November 9, 2023
·
1 min read
Press Releases
DeepCure to Present In Vivo Efficacy and Safety Data of BRD4 (BD2) Inhibitor DC-9476 for Macrophage Activation Syndrome at EMBO Conference
September 17, 2024
·
2 min read
Business
Elpiscience and Astellas Enter into Research Collaboration and License Agreement for Novel Bispecific Macrophage Engager
Elpiscience Biopharma, Ltd. and Astellas Pharma Inc. announced a research collaboration and license agreement for novel bi-specific macrophage engagers, ES019 and another program.
December 27, 2023
·
5 min read
1 of 26,102
Next
